Relevant Interviews, Disease and Trial Updates and Stock-Markets News posted by CRISPR Medicine News.
Always stay updated with the free CMN Newsletter.
Main (gene editing) focus: Novel gene- and cell therapies
Company stage: Clinical
Genome editing tool: CRISPR-Cas, base editing, CRISPRa/CRISPRi
Funding stage: Private
Location: Cambridge, MA, USA
Partnerships: Life Edit Therapeutics (acquired)
ElevateBio is a gene- and cell therapy company. It is engaged in the genome-editing field through its acquisition of Life Edit Therapeutics that develops novel CRISPR-Cas, base editing and CRISPRa/CRISPRi systems. The company anticipates to integrate these novel gene-editing technologies with its existing iPSC, viral vector, and cell engineering platforms.